Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
8.84
+0.59 (7.15%)
At close: Jul 25, 2025, 4:00 PM
8.95
+0.11 (1.22%)
After-hours: Jul 25, 2025, 7:55 PM EDT
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $465.25 million as of July 25, 2025. Its market cap has increased by 252.45% in one year.
Market Cap
465.25M
Enterprise Value
394.04M
1-Year Change
252.45%
Ranking
Category
Stock Price
$8.84
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $465.25M, an increase of 30.09%. That is a compound annual growth rate of 3.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 465.25M | -10.94% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | 7.40B | 134.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.58B |
| Johnson & Johnson | 405.32B |
| AbbVie | 336.11B |
| Novo Nordisk | 315.59B |
| UnitedHealth Group | 254.96B |
| Novartis AG | 225.74B |
| AstraZeneca | 225.08B |
| Abbott Laboratories | 220.16B |